Smithfield Trust Co. Sells 30 Shares of Intuitive Surgical Inc. (ISRG)
Smithfield Trust Co. reduced its position in Intuitive Surgical Inc. (NASDAQ:ISRG) by 4.2% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 680 shares of the company’s stock after selling 30 shares during the period. Smithfield Trust Co.’s holdings in Intuitive Surgical were worth $450,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in ISRG. 1832 Asset Management L.P. bought a new stake in shares of Intuitive Surgical during the first quarter worth $87,448,000. Strs Ohio boosted its stake in shares of Intuitive Surgical by 6,226.9% in the second quarter. Strs Ohio now owns 47,895 shares of the company’s stock worth $31,678,000 after buying an additional 47,138 shares in the last quarter. Credit Agricole S A boosted its stake in shares of Intuitive Surgical by 648.1% in the first quarter. Credit Agricole S A now owns 47,606 shares of the company’s stock worth $28,613,000 after buying an additional 41,242 shares in the last quarter. Lazard Asset Management LLC boosted its stake in shares of Intuitive Surgical by 18.3% in the first quarter. Lazard Asset Management LLC now owns 242,700 shares of the company’s stock worth $145,874,000 after buying an additional 37,500 shares in the last quarter. Finally, Bank of Montreal Can bought a new stake in shares of Intuitive Surgical during the second quarter worth $22,998,000. 91.90% of the stock is owned by institutional investors.
Shares of Intuitive Surgical Inc. (NASDAQ:ISRG) traded down 0.09% on Friday, hitting $712.77. The stock had a trading volume of 112,135 shares. Intuitive Surgical Inc. has a 12-month low of $461.05 and a 12-month high of $727.25. The company has a 50 day moving average of $700.61 and a 200-day moving average of $662.91. The firm has a market capitalization of $27.44 billion, a P/E ratio of 40.45 and a beta of 0.72.
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 19th. The company reported $5.62 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.65. The firm had revenue of $670 million for the quarter, compared to analysts’ expectations of $640.69 million. Intuitive Surgical had a net margin of 26.80% and a return on equity of 15.25%. During the same quarter in the previous year, the firm posted $4.57 earnings per share. Equities analysts predict that Intuitive Surgical Inc. will post $21.30 EPS for the current fiscal year.
ISRG has been the subject of a number of analyst reports. Leerink Swann reaffirmed an “outperform” rating and issued a $780.00 price target on shares of Intuitive Surgical in a research report on Monday, September 19th. Northland Securities cut Intuitive Surgical from a “market perform” rating to an “under perform” rating and set a $600.00 price target for the company. in a research report on Thursday, July 21st. Canaccord Genuity boosted their price target on Intuitive Surgical from $700.00 to $750.00 and gave the stock a “buy” rating in a research report on Wednesday, July 20th. Bank of America Corp. reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Wednesday, June 22nd. Finally, Stifel Nicolaus boosted their price target on Intuitive Surgical from $700.00 to $800.00 and gave the stock a “buy” rating in a research report on Wednesday, July 20th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $701.42.
In other news, CEO Gary S. Guthart sold 13,400 shares of Intuitive Surgical stock in a transaction on Monday, August 1st. The shares were sold at an average price of $698.00, for a total transaction of $9,353,200.00. Following the transaction, the chief executive officer now owns 78,780 shares in the company, valued at $54,988,440. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Mark J. Meltzer sold 3,000 shares of Intuitive Surgical stock in a transaction on Monday, August 22nd. The stock was sold at an average price of $688.33, for a total transaction of $2,064,990.00. Following the transaction, the senior vice president now owns 2,331 shares in the company, valued at approximately $1,604,497.23. The disclosure for this sale can be found here. Company insiders own 3.10% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.